<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="SARS and MERS epidemics combined [4]. To date no registered" exact="treatment" post="or vaccine for the disease exists. Various general treatments,"/>
 <result pre="in severely ill patients [6]. The absence of a specific" exact="treatment" post="and the high mortality rate dictate an urgent need"/>
 <result pre="host defense and are induced during stress, such as viral" exact="infection" post="[16]. An excess of ROS, such as in viral"/>
 <result pre="significant role for ACE2 in infectivity and the course of" exact="infection" post="[27]. ACE and ACE2 serve opposing physiological functions. After"/>
 <result pre="(iNOS) [34]. In host cells iNOS is commonly elevated during" exact="infection" post="by viruses, and in SARS-CoV-1 infection, NO inhibits viral"/>
 <result pre="Consequently, exogenous NO for targeted patient populations may be a" exact="treatment" post="that can reduce viral load in the lungs, prevent"/>
 <result pre="pro-drugs relying on enzymatic activity [43]. Inhaled NO (iNO) for" exact="treatment" post="of active ARDS was reported by Chen and colleagues"/>
 <result pre="in the management of ARDS [45,46]. Variations in dosing and" exact="treatment" post="protocol may at least partly account for the differences"/>
 <result pre="of iNO or RSNO at the early stages of COVID-19" exact="infection" post="might limit the progression toward ARDS and fulminant systemic"/>
 <result pre="treating COVID-19. On March 30 Bellerophon Therapeutics announced the first" exact="treatment" post="of a patient with COVID-19 using their proprietary INOpulseÂ®"/>
 <result pre="geared toward the right population at the optimal stage of" exact="infection" post="may be an accessible, compelling option for patients. If"/>
 <result pre="as therapeutics firms seek its indication for COVID-19, nitric oxide" exact="treatment" post="can be pivotal in the world's fight against this"/>
 <result pre="novel diagnostic and therapeutic target in sepsisCrit. Care23120191630654825 33LeeT.F.JantzieL.L.ToddK.G.CheungP.Y.Postresuscitation N-acetylcysteine" exact="treatment" post="reduces cerebral hydrogen peroxide in the hypoxic piglet brainIntensive"/>
 <result pre="syndromeN. Engl. J. Med.328619933994058357359 38ChenL.LiuP.GaoH.Inhalation of nitric oxide in the" exact="treatment" post="of severe acute respiratory syndrome: a rescue trial in"/>
 <result pre="and possible future therapeutic applicationsCurr. Med. Chem.112020042679269015544469 48KeyaertsE.VijgenL.ChenL.Inhibition of SARS-coronavirus" exact="infection" post="in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compoundInt."/>
</results>
